ANZUPGO vs JAKAFI XR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ANZUPGO and JAKAFI XR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANZUPGO	JAKAFI XR
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DELGOCITINIB	RUXOLITINIB PHOSPHATE
Manufacturer	Leo Pharma As	Incyte Corp
Dosage forms	Topical	Tablet, extended release
Drug class	Janus Kinase Inhibitor	Janus Kinase Inhibitor
Boxed warning	None	None
Treats	Eczema	Polycythemia Vera, Primary Myelofibrosis

anzupgo jakafi xr

Rating

New

Pharmacy pays

—

Type

Active ingredient

DELGOCITINIB

RUXOLITINIB PHOSPHATE

Manufacturer

Leo Pharma As

Incyte Corp

Dosage forms

Topical

Tablet, extended release

Drug class

Janus Kinase Inhibitor

Boxed warning

None

Treats

Eczema

Polycythemia Vera, Primary Myelofibrosis

Frequently asked questions

What is the difference between Anzupgo and Jakafi XR?

Anzupgo contains Delgocitinib, while Jakafi XR contains Ruxolitinib Phosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.